BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 27, 2007
View Archived Issues
Trial results support further investigation of sunitinib in non-small cell lung cancer
Read More
Clinical benefit seen with nimotuzumab in non-small cell lung cancer
Read More
Degarelix suppresses PSA, testosterone in prostate cancer patients
Read More
Sleep maintenance promoting effects of the 5-HT2A receptor antagonist eplivanserin shown in rats
Read More
Single-agent talactoferrin improves survival in refractory non-small cell lung cancer
Read More
Preclinical characterization of ARH-460-16-2, a novel anti-CD44 MAb
Read More
Telmisartan exerts potent PPAR-gamma-mediated antiproliferative activity against PC cells
Read More
Inhibition of calcineurin activity using tacrolimus restores memory in a mouse model of AD
Read More
Zelos reports positive results of phase I and II trials of Ostabolin-C
Read More
Studies reveal increased bone formation with anti-sclerostin antibody
Read More
Topical amitriptyline ineffective in treating neuropathic pain
Read More
Chelsea reports plans for phase III trials of droxidopa for NOH
Read More
Ariad begins phase III trial of deforolimus for metastatic soft-tissue and bone sarcomas
Read More
Positive results for DOV Pharmaceutical's phase Ib trial of DOV-21947
Read More
Encysive will conduct additional phase III study of Thelin in PAH
Read More
Cell Therapeutics begins FDA-approved, phase III advanced NSCLC trial in women
Read More
Inflazyme and Biolipox to enter asset purchase agreement
Read More
Lundbeck in-licenses Circadin from Neurim
Read More
Phase I clinical trial approved for transdermal oxycodone
Read More
EMEA grants orphan drug designation to HDAC inhibitor MGCD-0103
Read More
Allos completes interim analyses of pivotal phase II trial of PDX for PTCL
Read More
Array BioPharma and Celgene sign cancer and inflammation therapeutics agreement
Read More
Update on Progen's development of PI-88 for cancer
Read More
Schering-Plough begins phase I trial of PS-948115 for respiratory disease
Read More
AstraZeneca acquires North American rights to Verus' asthma development programs
Read More
In vivo Gram-positive antibacterial activity of novel oxazolidinone compounds
Read More
Biodel's two ongoing pivotal phase III trials of VIAject to include European sites
Read More
Recent patents divulge novel analgesic agents
Read More
Recent patents disclose new anxiolytic, antidepressive and antipsychotic agents
Read More